Join to View Full Profile
719 Carolina StSan Francisco, CA 94107
Phone+1 650-450-7477
Fax+1 415-970-9593
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Philip Sager, MD is a cardiologist in San Francisco, California. He is currently licensed to practice medicine in California, Alabama, and New Jersey.
Education & Training
Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1985 - 1988- Yale-New Haven Medical CenterResidency, Internal Medicine, 1983 - 1985
Yale School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1988 - 2026
PA State Medical License 2001 - 2014
IL State Medical License 2000 - 2005
NJ State Medical License 2001 - 2005
AL State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Self-Administered Etripamil Nasal Spray Relieved Symptoms, Decreased Heart Rate, and Reduced Medical Interventions During Atrioventricular Nodal-Dependent Paroxysmal S...Bruce S Stambler, Benoit Coutu, James E Ip, Blandine Mondésert, A Shekhar Pandey
Circulation. Arrhythmia and Electrophysiology. 2024-12-01 - 2 citationsEtripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 ...James E Ip, Benoit Coutu, Matthew T Bennett, A Shekhar Pandey, Bruce S Stambler
Journal of the American Heart Association. 2023-10-03 - 5 citationsSelf-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multi...Bruce S Stambler, A John Camm, Marco Alings, Paul Dorian, Hein Heidbuchel
Lancet. 2023-07-08
Press Mentions
Chutes & Ladders—Merck's Vaxneuvance Lead Exits to Make Rival Vaccine at AffinivaxAugust 13th, 2021- A Canadian Startup Refuels to Take on a Rare Cardiac Condition That Many Patients Don't Realize They HaveAugust 10th, 2021
- LQT Therapeutics Announces Closing of US$19M Series A Financing to Advance Lead Compound Through Phase 1 While Advancing Portfolio AssetsAugust 10th, 2021
